Eosinophilic Asthma Study

Ages

18-75

Study Topic

Respiratory

Compensation

Up to $900*

Asthma Trials in Columbus

Aventiv Research is currently participating in an Eosinophilic Asthma Study at our Dublin, Ohio location. Asthma is a chronic lung disease that affects about 1 in 12 people, and that number continues to grow. The disease inflames and narrows airways, thus causing periods of chest tightness, coughing, shortness of breath, and wheezing on a recurring basis.

Eosinophilic Asthma Study

The primary objective of this clinical trial is to evaluate the efficacy of an investigational drug in subjects with eosinophilic asthma. If you have been diagnosed with asthma and have frequent severe attacks and active symptoms despite using preventative medications, you may be interested in a new investigational medication for the treatment of adults with eosinophilic asthma.

You may qualify for this study if:

  • You are between 18 and 75 years old
  • You have been diagnosed with asthma for at least 12 months
  • You have asthma requiring treatment with, at a minimum, low dose inhaled corticosteroids in combination with a maintenance inhaler, on a stable dose for at least 1 month before screening

Ready to Volunteer?

Volunteer today to see if you qualify for our Asthma clinical research study. *Qualified volunteers may be compensated for time and travel.